Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Oxford Square Capital Corp is an asset management business based in the US. Oxford Square Capital shares (OXSQ) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced investors
52-week range | USD$1.7347 - USD$4.2829 |
---|---|
50-day moving average | USD$3.7485 |
200-day moving average | USD$3.0107 |
Wall St. target price | USD$5 |
PE ratio | N/A |
Dividend yield | USD$0.708 (17.61%) |
Earnings per share (TTM) | USD$-0.469 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$40.7 million |
---|---|
Operating margin TTM | 78.02% |
Gross profit TTM | USD$62.7 million |
Return on assets TTM | 5.55% |
Return on equity TTM | -19.05% |
Profit margin | -105.21% |
Book value | $3.851 |
Market capitalisation | USD$197.4 million |
TTM: trailing 12 months
There are currently 176,003 Oxford Square Capital shares held short by investors – that's known as Oxford Square Capital's "short interest". This figure is 5.9% up from 166,167 last month.
There are a few different ways that this level of interest in shorting Oxford Square Capital shares can be evaluated.
Oxford Square Capital's "short interest ratio" (SIR) is the quantity of Oxford Square Capital shares currently shorted divided by the average quantity of Oxford Square Capital shares traded daily (recently around 391117.77777778). Oxford Square Capital's SIR currently stands at 0.45. In other words for every 100,000 Oxford Square Capital shares traded daily on the market, roughly 450 shares are currently held short.
However Oxford Square Capital's short interest can also be evaluated against the total number of Oxford Square Capital shares, or, against the total number of tradable Oxford Square Capital shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Oxford Square Capital's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Oxford Square Capital shares in existence, roughly 0 shares are currently held short) or 0.0039% of the tradable shares (for every 100,000 tradable Oxford Square Capital shares, roughly 4 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Oxford Square Capital.
Find out more about how you can short Oxford Square Capital stock.
Dividend payout ratio: 35.74% of net profits
Recently Oxford Square Capital has paid out, on average, around 35.74% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 10.45% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Oxford Square Capital shareholders could enjoy a 10.45% return on their shares, in the form of dividend payments. In Oxford Square Capital's case, that would currently equate to about $0.708 per share.
While Oxford Square Capital's payout ratio might seem fairly standard, it's worth remembering that Oxford Square Capital may be investing much of the rest of its net profits in future growth.
Oxford Square Capital's most recent dividend payout was on 31 December 2018. The latest dividend was paid out to all shareholders who bought their shares by 16 March 2021 (the "ex-dividend date").
Over the last 12 months, Oxford Square Capital's shares have ranged in value from as little as $1.7347 up to $4.2829. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oxford Square Capital's is 1.2321. This would suggest that Oxford Square Capital's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans. The firm primarily invests in debt and/or equity securities of technology-related companies that operate in the computer software, Internet, information technology infrastructure and services, media, telecommunications and telecommunications equipment, semiconductors, hardware, technology-enabled services, semiconductor capital equipment, medical device technology, diversified technology, and networking systems sectors. It concentrates its investments in companies having annual revenues of less than $200 million and a market capitalization or enterprise value of less than $300 million. The firm invests between $5 million and $30 million per transaction. It seeks to exit its investments within 7 years. It serves as the investment adviser to TICC. Oxford Square Capital Corp., formerly known as TICC Capital Corp., was founded in 2003 and is headquartered in Greenwich, Connecticut.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.